Share Twitter LinkedIn Facebook Email Terry Mamounas, MD, MPH, FACS from Orlando Health Cancer Institute speaks about the SABCS 2021 Presentation – Refining Axillary Management After Neoadjuvant Chemotherapy – What Does The Evidence Support.
FDA Approves Datopotamab Deruxtecan / Datroway from Eli Lilly in Treatment for Unresectable or Metastatic HR-Positive, HER2-Negative Breast Cancer Breast 2 Mins Read
Can Imlunestrant Change the Future of Breast Cancer Treatment? Insights from SABCS with Virginia Kaklamani, MD Breast 3 Mins Read